<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.mlo-online.com/diagnostics/news/55414315/what-to-know-about-biomerieuxs-biofire-spotfire-vaginitis-panel-recently-dual-fda-cleared-and-clia-waived</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-26T14:05:04.000Z</news:publication_date><news:title>What to know about bioMérieux’s BIOFIRE SPOTFIRE Vaginitis Panel, recently Dual FDA-cleared and CLIA waived </news:title></news:news></url><url><loc>https://www.mlo-online.com/disease/hpv/news/55414309/labcorp-and-waters-partner-for-cervical-cancer-screening-access</loc><news:news><news:publication><news:name>MLO Online</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-26T14:00:43.000Z</news:publication_date><news:title>Labcorp and Waters partner for cervical cancer screening access</news:title></news:news></url></urlset>